首页 > 最新文献

中国综合临床最新文献

英文 中文
Analysis of neuroendoscopic or microscopic transsphenoidal approach in the treatment of pituitary tumors of different grades and the measures to reduce the common postoperative complications 神经内镜或显微经蝶入路治疗不同级别垂体瘤的疗效分析及减少术后常见并发症的措施
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.016
W. Dong, Cheng Yue, Yu Zhang, Jianjun Gao, G. Dong, Hua Gao
Objective To explore the clinical effect of endoscopic assisted or microscopical transsphenoidal surgery in the treatment of different grades of invasive pituitary tumors and the measures to reduce complications. Methods From January 2016 to June 2019, 87 patients with pituitary tumor admitted to the neurosurgery of Tangshan People′s Hospital of Hebei Province were selected as the study objects for retrospective analysis. Among them, 42 patients were included in the endoscopic group and 45 patients were included in the endoscopic group. To compare the related indexes and clinical effects of two different surgical methods, and to analyze the treatment strategies to reduce the common postoperative complications. Results The amount of intraoperative bleeding, the time needed for operation and the hospital stay of patients in endoscopic group were significantly less or shorter than those in microscopical group(intraoperative bleeding volume: (66.19±9.55) ml and (79.78±11.68) ml; operation time: (93.93±9.53) min and (103.33±9.23) min; hospitalization time: (7.71±1.53) d and (10.16±1.33) d). The difference was statistically significant (T values were 5.92, 4.67, 7.94, all P< 0.01). There was no significant difference between the two groups (P= 0.577). There were 2 cases (4.8%) of cerebrospinal fluid leakage in endoscopic group and 12 cases (26.7%) in microscopical group. The difference between the two groups was statistically significant(χ2=5.67, P< 0.05). There were 7 cases (16.7%) of diabetes insipidus in endoscopic group and 22 cases (48.9%) in microscopical group. The difference between the two groups was statistically significant (χ2=5.19, P< 0.05). Conclusion The curative effect of endoscopic transsphenoidal resection of pituitary tumor is similar to that of microscopical resection of pituitary tumor. The patients recover quickly, have fewer complications, and have a short hospital stay. Key words: Neuroendoscopy; Microscope; Pituitary tumor; Complication
目的探讨内镜辅助或显微镜下经蝶窦手术治疗不同级别侵袭性垂体瘤的临床效果及减少并发症的措施。方法选择2016年1月至2019年6月河北省唐山市人民医院神经外科收治的87例垂体瘤患者作为研究对象进行回顾性分析。其中,内镜组42例,内镜组45例。比较两种不同手术方法的相关指标和临床效果,分析减少术后常见并发症的治疗策略。结果内镜组术中出血量、手术时间和住院时间均明显少于或缩短显微镜组(术中出血体积:(66.19±9.55)ml和(79.78±11.68)ml;手术时间:(93.93±9.53)min和(103.33±9.23)min;住院时间:(7.71±1.53)d和(10.16±1.33)d)。差异有统计学意义(T值分别为5.92、4.67、7.94,均P<0.01),两组比较无统计学意义(P=0.577),内镜组脑脊液漏2例(4.8%),显微镜组脑脊液漏12例(26.7%)。两组比较差异有统计学意义(χ2=5.67,P<0.05),其中内镜组尿崩症7例(16.7%),显微镜组22例(48.9%)。两组比较有统计学意义(χ2=5.19,P<0.05)。患者恢复迅速,并发症较少,住院时间短。关键词:神经内窥镜检查;显微镜;垂体瘤;并发症
{"title":"Analysis of neuroendoscopic or microscopic transsphenoidal approach in the treatment of pituitary tumors of different grades and the measures to reduce the common postoperative complications","authors":"W. Dong, Cheng Yue, Yu Zhang, Jianjun Gao, G. Dong, Hua Gao","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.016","url":null,"abstract":"Objective \u0000To explore the clinical effect of endoscopic assisted or microscopical transsphenoidal surgery in the treatment of different grades of invasive pituitary tumors and the measures to reduce complications. \u0000 \u0000 \u0000Methods \u0000From January 2016 to June 2019, 87 patients with pituitary tumor admitted to the neurosurgery of Tangshan People′s Hospital of Hebei Province were selected as the study objects for retrospective analysis. Among them, 42 patients were included in the endoscopic group and 45 patients were included in the endoscopic group. To compare the related indexes and clinical effects of two different surgical methods, and to analyze the treatment strategies to reduce the common postoperative complications. \u0000 \u0000 \u0000Results \u0000The amount of intraoperative bleeding, the time needed for operation and the hospital stay of patients in endoscopic group were significantly less or shorter than those in microscopical group(intraoperative bleeding volume: (66.19±9.55) ml and (79.78±11.68) ml; operation time: (93.93±9.53) min and (103.33±9.23) min; hospitalization time: (7.71±1.53) d and (10.16±1.33) d). The difference was statistically significant (T values were 5.92, 4.67, 7.94, all P< 0.01). There was no significant difference between the two groups (P= 0.577). There were 2 cases (4.8%) of cerebrospinal fluid leakage in endoscopic group and 12 cases (26.7%) in microscopical group. The difference between the two groups was statistically significant(χ2=5.67, P< 0.05). There were 7 cases (16.7%) of diabetes insipidus in endoscopic group and 22 cases (48.9%) in microscopical group. The difference between the two groups was statistically significant (χ2=5.19, P< 0.05). \u0000 \u0000 \u0000Conclusion \u0000The curative effect of endoscopic transsphenoidal resection of pituitary tumor is similar to that of microscopical resection of pituitary tumor. The patients recover quickly, have fewer complications, and have a short hospital stay. \u0000 \u0000 \u0000Key words: \u0000Neuroendoscopy; Microscope; Pituitary tumor; Complication","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49316856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Advances of metronomic Chemotherapy in Non-small Cell Lung Cancer 非小细胞肺癌癌症节拍化疗的研究进展
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.020
Yue Yu
Advanced non-small cell lung cancer is one of the most difficult malignant tumors in the world. At present, chemotherapy is the most common treatment for NSCLC. However, traditional chemotherapy can kill tumor cells as well as normal cells. In order to solve this problem, metronomic chemotherapy came into being. It can inhibit tumor angiogenesis and tumor growth through a continuous high-frequency, low-dose administration. Metronomic chemotherapy can effectively control the disease progression of advanced NSCLC patients, delay their life span and improve their quality of life. Therefore, metronomic chemotherapy has become an effective treatment for advanced non-small cell lung cancer. Key words: Lung cancer; Metronomic Chemotherapy; Tumor
晚期癌症是世界上最难治疗的恶性肿瘤之一。目前,化疗是NSCLC最常见的治疗方法。然而,传统的化疗可以杀死肿瘤细胞和正常细胞。为了解决这个问题,节拍化疗应运而生。它可以通过连续的高频、低剂量给药来抑制肿瘤血管生成和肿瘤生长。节拍化疗可以有效控制晚期NSCLC患者的疾病进展,延缓其寿命,提高其生活质量。因此,节拍化疗已成为晚期癌症的有效治疗手段。关键词:肺癌癌症;节拍化疗;肿瘤
{"title":"Research Advances of metronomic Chemotherapy in Non-small Cell Lung Cancer","authors":"Yue Yu","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.020","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.020","url":null,"abstract":"Advanced non-small cell lung cancer is one of the most difficult malignant tumors in the world. At present, chemotherapy is the most common treatment for NSCLC. However, traditional chemotherapy can kill tumor cells as well as normal cells. In order to solve this problem, metronomic chemotherapy came into being. It can inhibit tumor angiogenesis and tumor growth through a continuous high-frequency, low-dose administration. Metronomic chemotherapy can effectively control the disease progression of advanced NSCLC patients, delay their life span and improve their quality of life. Therefore, metronomic chemotherapy has become an effective treatment for advanced non-small cell lung cancer. \u0000 \u0000 \u0000Key words: \u0000Lung cancer; Metronomic Chemotherapy; Tumor","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45844113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of serum monokine induced by IFN-γ and interleukin9 to HBV pre-C/BCP mutation and their influences on the response to interferon therapy in patients with HBeAg-positive chronic hepatitis B IFN-γ和白细胞介素9诱导的血清单因子与hbeag阳性慢性乙型肝炎患者HBV前c /BCP突变的相关性及其对干扰素治疗应答的影响
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.015
Li Yang, Xiaoqing Hu
Objective To study the correlation of serum monokine induced by IFN-γ(Mig)and interleukin9(IL-9) levels to HBV pre-C/BCP mutation and their influences on the response to interferon therapy in patients with HBeAg-positive chronic hepatitis B(CHB). Methods A total of 110 cases of HBeAg-positive CHB patients in the People′s Hospital of Jianyang City were retrospectively analyzed from February 2015 to February 2018, and all received pegylated-IFN-αtherapy.Before treatment, the gene fragment of HBV pre-C/BCP region was amplified and the patients were divided into two groups: wild type group (61 cases) and mutant group (49 cases). The difference of serum MIG, IL-9 and antiviral treatment effect between the two groups were compared. Results The serum IL-9 of mutant group before treatment ((10.8±1.9) ng/L)was significantly higher than that of wild group((8.3±1.7) ng/L) (P 1 lg 10 in mutation group before treatment was significantly higher than HBsAg decrease≤1 lg 10 ((129.2±37.9) ng/L vs.(91.5±25.7) ng/L)(P<0.05). The serum IL-9 in the mutant group were(8.8±1.9) ng/L and (8.9±1.6) ng/L at 12 and 24 weeks after treatment respectively, which were significantly lower than that before treatment (all P<0.05). Conclusion The high expression of IL-9 in serum of CHB and HBeAg positive patients before treatment is closely related to the variation of HBV pre-C/BCP region, and the expression of IL-9 is not related to the antiviral effect of interferon.The high expression of MIG in patients before treatment may be more beneficial to the antiviral effect of interferon in patients with HBV pre-C/BCP region variation. Key words: Chronic hepatitis B; Hepatitis B virus pre-C/BCP mutation; Pegylated-IFN-α; Interleukin 9; Monokine induced by IFN-γ
目的研究干扰素-γ(Mig)和白细胞介素9(IL-9)诱导的血清单因子水平与乙型肝炎病毒前C/BCP突变的相关性及其对HBeAg阳性慢性乙型肝炎患者干扰素治疗反应的影响。方法回顾性分析建阳市人民医院2015年2月至2018年2月收治的110例HBeAg阳性慢性乙型肝炎患者,均接受聚乙二醇化IFN-α治疗。比较两组患者血清MIG、IL-9及抗病毒治疗效果的差异。结果突变组治疗前血清IL-9(10.8±1.9)ng/L明显高于野生组(8.3±1.7)ng/L(P<0.05),突变组治疗后12周和24周血清IL-9分别为(8.8±1.9)ng/L和(8.9±1.6)ng/L结论CHB和HBeAg阳性患者治疗前血清IL-9的高表达与HBV前C/BCP区的变异密切相关,IL-9的表达与干扰素的抗病毒作用无关。MIG在治疗前患者中的高表达可能更有利于干扰素在HBV前C/BCP区域变异患者中的抗病毒作用。关键词:慢性乙型肝炎;乙型肝炎病毒前C/BCP突变;聚乙二醇化IFN-α;白细胞介素9;IFN-γ诱导的单因子
{"title":"Correlation of serum monokine induced by IFN-γ and interleukin9 to HBV pre-C/BCP mutation and their influences on the response to interferon therapy in patients with HBeAg-positive chronic hepatitis B","authors":"Li Yang, Xiaoqing Hu","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.015","url":null,"abstract":"Objective \u0000To study the correlation of serum monokine induced by IFN-γ(Mig)and interleukin9(IL-9) levels to HBV pre-C/BCP mutation and their influences on the response to interferon therapy in patients with HBeAg-positive chronic hepatitis B(CHB). \u0000 \u0000 \u0000Methods \u0000A total of 110 cases of HBeAg-positive CHB patients in the People′s Hospital of Jianyang City were retrospectively analyzed from February 2015 to February 2018, and all received pegylated-IFN-αtherapy.Before treatment, the gene fragment of HBV pre-C/BCP region was amplified and the patients were divided into two groups: wild type group (61 cases) and mutant group (49 cases). The difference of serum MIG, IL-9 and antiviral treatment effect between the two groups were compared. \u0000 \u0000 \u0000Results \u0000The serum IL-9 of mutant group before treatment ((10.8±1.9) ng/L)was significantly higher than that of wild group((8.3±1.7) ng/L) (P 1 lg 10 in mutation group before treatment was significantly higher than HBsAg decrease≤1 lg 10 ((129.2±37.9) ng/L vs.(91.5±25.7) ng/L)(P<0.05). The serum IL-9 in the mutant group were(8.8±1.9) ng/L and (8.9±1.6) ng/L at 12 and 24 weeks after treatment respectively, which were significantly lower than that before treatment (all P<0.05). \u0000 \u0000 \u0000Conclusion \u0000The high expression of IL-9 in serum of CHB and HBeAg positive patients before treatment is closely related to the variation of HBV pre-C/BCP region, and the expression of IL-9 is not related to the antiviral effect of interferon.The high expression of MIG in patients before treatment may be more beneficial to the antiviral effect of interferon in patients with HBV pre-C/BCP region variation. \u0000 \u0000 \u0000Key words: \u0000Chronic hepatitis B; Hepatitis B virus pre-C/BCP mutation; Pegylated-IFN-α; Interleukin 9; Monokine induced by IFN-γ","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42403743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the treament of talus fracture and its complications 距骨骨折及其并发症的治疗进展
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.021
L. Ding, Shufeng Han, Erlong Jia, Jintao Chen, Chang Liu
Talus fracture is a relatively rare injury. The indication of surgical treatment of talus fracture is the obvious displacement of talus neck or talus body fracture, the purpose of which is to achieve anatomical reduction of the fracture site. The anatomical structure of talus is special, most of its surface is covered by the articular surface, so the injury often involves the articular surface, so the treatment is difficult and the incidence of complications after fracture operation is high, which is prone to ischemic necrosis and traumatic arthritis. Based on the anatomical structure of talus, we reviewed the latest treatment methods of talus fracture and its complications, the advantages and disadvantages of different treatment methods and the existing problems. Key words: Fracture; Talus; Ischemic necrosis; Treament
距骨骨折是一种相对罕见的损伤。距骨骨折手术治疗的指征是距骨颈明显移位或距骨体骨折,其目的是实现骨折部位的解剖复位。距骨解剖结构特殊,其表面大部分被关节面覆盖,因此损伤常累及关节面,因此治疗难度大,骨折手术后并发症发生率高,易发生缺血性坏死和外伤性关节炎。从距骨的解剖结构出发,综述了距骨骨折的最新治疗方法及其并发症、不同治疗方法的优缺点及存在的问题。关键词:断裂;距骨;缺血性坏死;救治
{"title":"Advances in the treament of talus fracture and its complications","authors":"L. Ding, Shufeng Han, Erlong Jia, Jintao Chen, Chang Liu","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.021","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.021","url":null,"abstract":"Talus fracture is a relatively rare injury. The indication of surgical treatment of talus fracture is the obvious displacement of talus neck or talus body fracture, the purpose of which is to achieve anatomical reduction of the fracture site. The anatomical structure of talus is special, most of its surface is covered by the articular surface, so the injury often involves the articular surface, so the treatment is difficult and the incidence of complications after fracture operation is high, which is prone to ischemic necrosis and traumatic arthritis. Based on the anatomical structure of talus, we reviewed the latest treatment methods of talus fracture and its complications, the advantages and disadvantages of different treatment methods and the existing problems. \u0000 \u0000 \u0000Key words: \u0000Fracture; Talus; Ischemic necrosis; Treament","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47918898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical observation and study of hormone replacement therapy on postoperative cervical squamous cell carcinoma 宫颈鳞状细胞癌术后激素替代治疗的临床观察与研究
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.004
Chengwei He, Tianqi Guo, P. Lei
Objective To observe the clinical effect of hormone replacement therapy(HRT) on patients with cervical squamous cell carcinoma after operation and its effect on sex hormone, blood fat, bone content and tumor markers, and to evaluate the clinical significance of HRT therapy. Methods From January 2016 to January 2019, a total of 100 patients with cervical squamous cell carcinoma admitted to Zhuhai Maternal and Child Health Hospital were analyzed retrospectively.After surgical treatment, 50 patients were willing to receive hormone replacement therapy as the experimental group and 50 patients received routine treatment as the control group, Kupperma score was used to evaluate the severity of perimenopausal symptoms, and the serum levels of sex hormones, blood fat, bone content and tumor markers in the two groups before and after treatment were detected and the occurrence of adverse reactions were evaluated. Results Before treatment, there was no significant difference in kupperma score, estradiol, follicle-stimulating hormone, luteinizing hormone level, lipid level, bone content and tumor marker level between the two groups(all P>0.05). After HRT treatment, kupperma score in the experimental group was significantly lower than that before treatment((11.47±5.12) vs.(20.46±7.52), t=7.262). In the detection of sex hormones, the levels of estradiol in the experimental group was significantly increased((39.26±7.43) ng/L vs.(13.78±7.52) ng/L, t=12.345), and the levels of follicle stimulating hormone((34.25±7.61) U/L vs.(62.18±19.12) U/L, t=8.245)and luteinizing hormone((20.31±6.25) U/L vs.(35.08±6.27) U/L, t=5.452, P=0.004) in the experimental group were significantly decreased.In the detection of blood lipid level, bone content and tumor markers, high-density lipoprotein((1.62±0.33) mmol/L vs(1.34±0.26) mmol/L, t=4.592, P=0.008) and alkaline phosphatase levels((66.21±25.75) U/L vs.(46.88±9.06) U/L, t=5.912, P=0.001)was significantly increased, the low density lipoprotein((2.78±0.43) mmol/L vs.(2.87±0.78) mmol/L, t=4.265, P=0.012)and total cholestenone((4.02±0.45) mmol/L vs.(4.23±0.91) mmol/L, t=5.761, P=0.002) levels were significantly decreased in the experimental group, with statistically significant differences(all P 0.05); there was no significant difference in the above indicators between the experimental group and the control group before and after treatment (P> 0.05); there was no significant increase in adverse reactions such as breast swelling and pain (3 cases), body mass increase (2 cases), bleeding (1 case), body pain (4 cases), vomiting (4 cases), etc. between the experimental group and the control group (2, 1, 2, 3, 1 case) There was no statistical significance (P> 0.05). Conclusion HRT treatment of cervical squamous cell carcinoma patients after surgery can significantly improve the peri menstrual syndrome caused by low estrogen level, and did not significantly increase the risk of recurrence of cervical cancer patients an
目的观察宫颈鳞状细胞癌术后激素替代疗法(HRT)的临床疗效及其对性激素、血脂、骨含量和肿瘤标志物的影响,评价激素替代疗法的临床意义。方法对2016年1月至2019年1月珠海市妇幼保健院收治的100例宫颈鳞状细胞癌患者进行回顾性分析。手术治疗后,50例愿意接受激素替代治疗的患者作为实验组,50例接受常规治疗的患者为对照组,采用Kupperma评分评估围绝经期症状的严重程度,检测两组患者治疗前后的骨含量和肿瘤标志物,并评估不良反应的发生情况。结果治疗前两组患者库珀玛评分、雌二醇、卵泡刺激素、促黄体生成素水平、脂质水平、骨含量及肿瘤标志物水平差异无统计学意义(均P>0.05),在性激素检测中,实验组雌二醇水平显著升高((39.26±7.43)ng/L对(13.78±7.52)ng/L,t=12.345),卵泡刺激素水平(34.25±7.61)U/L对(62.18±19.12)U/L,t=8.245)和黄体生成素水平(20.31±6.25)U/L比(35.08±6.27)U/L,P=0.004)显著降低。在血脂水平、骨含量和肿瘤标志物的检测中,高密度脂蛋白((1.62±0.33)mmol/L vs(1.34±0.26)mmol/L,t=4.592,P=0.008)和碱性磷酸酶水平((66.21±25.75)U/L vs(46.88±9.06)U/L,t=5.912,P=0.001)显著升高,低密度脂蛋白,P=0.012)和总胆固醇酮((4.02±0.45)mmol/L vs.(4.23±0.91)mmol/L,t=5.761,P=0.002)水平在实验组中显著降低,具有统计学意义(均P 0.05);实验组与对照组治疗前后上述指标差异无统计学意义(P>0.05);不良反应如乳房肿胀疼痛(3例)、体重增加(2例)、出血(1例)、身体疼痛(4例)、呕吐(4例,实验组与对照组(2、1、2、3、1例)比较无统计学意义(P>0.05),并没有显著增加宫颈癌症患者的复发风险和不良反应。关键词:激素替代疗法;宫颈鳞状细胞癌;临床观察
{"title":"Clinical observation and study of hormone replacement therapy on postoperative cervical squamous cell carcinoma","authors":"Chengwei He, Tianqi Guo, P. Lei","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.004","url":null,"abstract":"Objective \u0000To observe the clinical effect of hormone replacement therapy(HRT) on patients with cervical squamous cell carcinoma after operation and its effect on sex hormone, blood fat, bone content and tumor markers, and to evaluate the clinical significance of HRT therapy. \u0000 \u0000 \u0000Methods \u0000From January 2016 to January 2019, a total of 100 patients with cervical squamous cell carcinoma admitted to Zhuhai Maternal and Child Health Hospital were analyzed retrospectively.After surgical treatment, 50 patients were willing to receive hormone replacement therapy as the experimental group and 50 patients received routine treatment as the control group, Kupperma score was used to evaluate the severity of perimenopausal symptoms, and the serum levels of sex hormones, blood fat, bone content and tumor markers in the two groups before and after treatment were detected and the occurrence of adverse reactions were evaluated. \u0000 \u0000 \u0000Results \u0000Before treatment, there was no significant difference in kupperma score, estradiol, follicle-stimulating hormone, luteinizing hormone level, lipid level, bone content and tumor marker level between the two groups(all P>0.05). After HRT treatment, kupperma score in the experimental group was significantly lower than that before treatment((11.47±5.12) vs.(20.46±7.52), t=7.262). In the detection of sex hormones, the levels of estradiol in the experimental group was significantly increased((39.26±7.43) ng/L vs.(13.78±7.52) ng/L, t=12.345), and the levels of follicle stimulating hormone((34.25±7.61) U/L vs.(62.18±19.12) U/L, t=8.245)and luteinizing hormone((20.31±6.25) U/L vs.(35.08±6.27) U/L, t=5.452, P=0.004) in the experimental group were significantly decreased.In the detection of blood lipid level, bone content and tumor markers, high-density lipoprotein((1.62±0.33) mmol/L vs(1.34±0.26) mmol/L, t=4.592, P=0.008) and alkaline phosphatase levels((66.21±25.75) U/L vs.(46.88±9.06) U/L, t=5.912, P=0.001)was significantly increased, the low density lipoprotein((2.78±0.43) mmol/L vs.(2.87±0.78) mmol/L, t=4.265, P=0.012)and total cholestenone((4.02±0.45) mmol/L vs.(4.23±0.91) mmol/L, t=5.761, P=0.002) levels were significantly decreased in the experimental group, with statistically significant differences(all P 0.05); there was no significant difference in the above indicators between the experimental group and the control group before and after treatment (P> 0.05); there was no significant increase in adverse reactions such as breast swelling and pain (3 cases), body mass increase (2 cases), bleeding (1 case), body pain (4 cases), vomiting (4 cases), etc. between the experimental group and the control group (2, 1, 2, 3, 1 case) There was no statistical significance (P> 0.05). \u0000 \u0000 \u0000Conclusion \u0000HRT treatment of cervical squamous cell carcinoma patients after surgery can significantly improve the peri menstrual syndrome caused by low estrogen level, and did not significantly increase the risk of recurrence of cervical cancer patients an","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48281488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the efficacy of midcaudal combined approach and cephalic middle approach in laparoscopic complete mesocolic excision for right hemicolon cancer with incomplete ileus 尾中联合入路与头中入路在腹腔镜右半结肠癌不完全肠梗阻全肠系膜切除术中的疗效比较
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.006
Hongsheng Zhao, Jiyong Pan, Ruifeng Yan, Zijun Guo, Long Yan
Objective To compare the effect of midcaudal combined approach and the cephalic middle approach in laparoscopic complete mesocolic excision (CME) in the treatment of right colon cancer complicated with incomplete intestinal obstruction. Methods From January 2014 to January 2019, 90 patients with right colon cancer complicated with incomplete intestinal obstruction admitted to the Third People′s Hospital of Dalian were retrospectively analyzed.All patients underwent laparoscopic right hemicolectomy, CME plus D3 lymph node dissection.According to the choice of different surgical approaches, 44 patients were treated with the midcaudal combined approach (observation group) and the other 46 patients were treated with cephalic middle approach (control group). The intraoperative, postoperative and complications of the two groups were compared statistically. Results Compared with the control group, the bleeding volume in the observation group was significantly reduced ((105.3±22.6) ml vs.(309.6±28.0) ml, t=13.698), the operation time was significantly shortened ((165.2±17.9) min vs.(219.5±21.5) min, t=8.327), and the differences were statistically significant (all P 0.05). Conclusion It is safe and feasible to use the middle caudal approach in laparoscopic CME for right colon cancer complicated with incomplete ileus. Compared with the cephalic middle approach, it can reduce thebleeding volume and shorten the operation time. Key words: Right colon cancer; Incomplete intestinal obstruction; Complete mesocolon resection; Midcaudal combined approach
目的比较腹腔镜下完全性中结肠切除术(CME)中尾联合入路与头中入路治疗右半结肠癌合并不完全性肠梗阻的疗效。方法回顾性分析2014年1月至2019年1月大连市第三人民医院收治的90例右半结肠癌合并不完全性肠梗阻患者的临床资料。所有患者均行腹腔镜右半结肠切除术、CME加D3淋巴结清扫术。根据不同手术入路的选择,44例患者采用中-尾联合入路(观察组),46例患者采用头-中入路(对照组)。对两组患者术中、术后及并发症进行统计学比较。结果与对照组相比,观察组出血量明显减少((105.3±22.6)ml vs.(309.6±28.0)ml,t=13.698),手术时间明显缩短((165.2±17.9)min vs.(219.5±21.5)min,t=8.327),结论应用中尾入路腹腔镜右结肠癌合并不完全性肠梗阻行CME是安全可行的。与头正中入路相比,可减少出血量,缩短手术时间。关键词:右结肠癌癌症;不完全性肠梗阻;完全性结肠系膜切除术;中尾联合入路
{"title":"Comparison of the efficacy of midcaudal combined approach and cephalic middle approach in laparoscopic complete mesocolic excision for right hemicolon cancer with incomplete ileus","authors":"Hongsheng Zhao, Jiyong Pan, Ruifeng Yan, Zijun Guo, Long Yan","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.006","url":null,"abstract":"Objective \u0000To compare the effect of midcaudal combined approach and the cephalic middle approach in laparoscopic complete mesocolic excision (CME) in the treatment of right colon cancer complicated with incomplete intestinal obstruction. \u0000 \u0000 \u0000Methods \u0000From January 2014 to January 2019, 90 patients with right colon cancer complicated with incomplete intestinal obstruction admitted to the Third People′s Hospital of Dalian were retrospectively analyzed.All patients underwent laparoscopic right hemicolectomy, CME plus D3 lymph node dissection.According to the choice of different surgical approaches, 44 patients were treated with the midcaudal combined approach (observation group) and the other 46 patients were treated with cephalic middle approach (control group). The intraoperative, postoperative and complications of the two groups were compared statistically. \u0000 \u0000 \u0000Results \u0000Compared with the control group, the bleeding volume in the observation group was significantly reduced ((105.3±22.6) ml vs.(309.6±28.0) ml, t=13.698), the operation time was significantly shortened ((165.2±17.9) min vs.(219.5±21.5) min, t=8.327), and the differences were statistically significant (all P 0.05). \u0000 \u0000 \u0000Conclusion \u0000It is safe and feasible to use the middle caudal approach in laparoscopic CME for right colon cancer complicated with incomplete ileus. Compared with the cephalic middle approach, it can reduce thebleeding volume and shorten the operation time. \u0000 \u0000 \u0000Key words: \u0000Right colon cancer; Incomplete intestinal obstruction; Complete mesocolon resection; Midcaudal combined approach","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41458618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the treatment course of Bifidobacterium combined with quadruple therapy including furazolidone and tetracycline for rescue eradication of Helicobacter pylori 双歧杆菌联合呋喃唑酮四环素三联疗法抢救性根除幽门螺杆菌的疗程研究
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.007
Haitao Wang, Jie Zhang, Xiaozhong Jiang
Objective To explore the effect of the eradication rate and adverse reactions of different courses of Bifidobacterium combined with quadruple therapy containing furazolidone and tetracycline for rescue eradication of Helicobacter pylori. Methods From December 2016 to May 2019, 348 patients with chronic gastritis who failed to eradicate Hp for the first time were selected from the outpatient department of digestive medicine of Kailuan General Hospital affiliated to North China University of Technology.Group A, B and C were randomly divided by Excel, Group A(116 patients): 14-day quadruple therapy (Eprazole+ colloidal bismuth pectin+ furazolidone + tetracycline); group B(116 patients): Bifidobacterium was given 14 days on the basis of treatment in group A; group C(116 patients): 7 days Bifidobacterium was given in the second week of treatment in group A 4 weeks after the end of eradication treatment, 14 C urea breath test was reexamined, to compare the eradication rate and the incidence of adverse reactions. Results The eradication rates were 80.2%, 84.5% and 82.3% respectively according to intention treatment.The eradication rates were 88.6%, 90.7% and 89.7%, respectively according to perprotocol.There was no significant difference between the three groups(according to intention to treat analysis: χ2=0.755, P=0.685; according to the perprotocol analysis: χ2=0.271, P=0.873). The incidence of adverse reactions in three groups was 16.4%, 6.3% and 7.3% respectively, the difference was statistically significant(χ2=7.561, P=0.023). Group B was significantly lower than group A(χ2=5.570, P=0.017), the difference was statistically significant, but there was no statistically significant difference between group C and group A(χ2=4.362, P=0.037). Conclusion After 14 days of Bifidobacterium tetrad live tablet assisted with tetrad therapy containing furazolidone and tetracycline, the adverse reactions could be significantly reduced, but Bifidobacterium could not significantly improve the eradication rate. Key words: Helicobacter pylori; Quadruple therapy; Eradication rate; Rescue eradication therapy; Bifidobacterium
目的探讨双歧杆菌不同疗程联合呋喃唑酮和四环素四联疗法抢救根除幽门螺杆菌的效果及不良反应。方法选取2016年12月至2019年5月华北工业大学附属开滦总医院消化内科门诊首次Hp根除失败的慢性胃炎患者348例。A、B、C组采用Excel随机分组,A组(116例):14 d四联治疗(依哌唑+胶态铋果胶+呋喃唑酮+四环素);B组116例:在A组治疗的基础上给予双歧杆菌治疗14 d;C组(116例):治疗第2周给予双歧杆菌治疗,A组根除治疗结束4周后复查14c尿素呼气试验,比较根除率和不良反应发生率。结果意向治疗的根除率分别为80.2%、84.5%和82.3%。根据perprotocol,根除率分别为88.6%、90.7%和89.7%。三组间差异无统计学意义(按治疗意向分析:χ2=0.755, P=0.685;超协议分析:χ2=0.271, P=0.873)。三组患者不良反应发生率分别为16.4%、6.3%、7.3%,差异有统计学意义(χ2=7.561, P=0.023)。B组明显低于A组(χ2=5.570, P=0.017),差异有统计学意义;C组与A组比较,差异无统计学意义(χ2=4.362, P=0.037)。结论双歧杆菌四活片配合呋喃唑酮和四环素四活片治疗14 d后,不良反应明显减少,但双歧杆菌的根除率没有明显提高。关键词:幽门螺杆菌;四联疗法治疗过程中;根除率;抢救根除疗法;双歧杆菌属
{"title":"Study on the treatment course of Bifidobacterium combined with quadruple therapy including furazolidone and tetracycline for rescue eradication of Helicobacter pylori","authors":"Haitao Wang, Jie Zhang, Xiaozhong Jiang","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.007","url":null,"abstract":"Objective \u0000To explore the effect of the eradication rate and adverse reactions of different courses of Bifidobacterium combined with quadruple therapy containing furazolidone and tetracycline for rescue eradication of Helicobacter pylori. \u0000 \u0000 \u0000Methods \u0000From December 2016 to May 2019, 348 patients with chronic gastritis who failed to eradicate Hp for the first time were selected from the outpatient department of digestive medicine of Kailuan General Hospital affiliated to North China University of Technology.Group A, B and C were randomly divided by Excel, Group A(116 patients): 14-day quadruple therapy (Eprazole+ colloidal bismuth pectin+ furazolidone + tetracycline); group B(116 patients): Bifidobacterium was given 14 days on the basis of treatment in group A; group C(116 patients): 7 days Bifidobacterium was given in the second week of treatment in group A 4 weeks after the end of eradication treatment, 14 C urea breath test was reexamined, to compare the eradication rate and the incidence of adverse reactions. \u0000 \u0000 \u0000Results \u0000The eradication rates were 80.2%, 84.5% and 82.3% respectively according to intention treatment.The eradication rates were 88.6%, 90.7% and 89.7%, respectively according to perprotocol.There was no significant difference between the three groups(according to intention to treat analysis: χ2=0.755, P=0.685; according to the perprotocol analysis: χ2=0.271, P=0.873). The incidence of adverse reactions in three groups was 16.4%, 6.3% and 7.3% respectively, the difference was statistically significant(χ2=7.561, P=0.023). Group B was significantly lower than group A(χ2=5.570, P=0.017), the difference was statistically significant, but there was no statistically significant difference between group C and group A(χ2=4.362, P=0.037). \u0000 \u0000 \u0000Conclusion \u0000After 14 days of Bifidobacterium tetrad live tablet assisted with tetrad therapy containing furazolidone and tetracycline, the adverse reactions could be significantly reduced, but Bifidobacterium could not significantly improve the eradication rate. \u0000 \u0000 \u0000Key words: \u0000Helicobacter pylori; Quadruple therapy; Eradication rate; Rescue eradication therapy; Bifidobacterium","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46729129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of interleukin6 on the malignant progression of ovarian cancer 白细胞介素6对卵巢癌恶性进展的影响
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.018
Tongshuo Zhang, Ziyue Zhang, Weixin Li, Xiaoqin Guo
Modern oncology believes that tumor-associated inflammation is one of the prominent features of tumor microenvironment.The occurrence and development of ovarian cancer is inseparable from the influence of inflammatory factors in the microenvironment.Interleukin-6 (IL-6) is an important pro-inflammatory factor that regulates tumor cell growth.Current studies found that the expression of IL-6 and IL-6 receptor both increase in patients with ovarian cancer, which are closely related to poor clinical prognosis.The mechanism of effect of IL-6 on the malignant progression of ovarian cancer has been a research hotspots in the field of tumor microenvironment.In combination of the research results of this group in recent years, we mainly review the role of IL-6 in ovarian cancer including proliferation, invasion and metastasis, blood system disorders and drug resistance.Then, we introduce the research frontiers and application prospects of IL-6 targeted therapy for ovary cancer. Key words: Ovarian cancer; Interleukin6; Inflammation; Tumor microenvironment; Malignant progression
现代肿瘤学认为,肿瘤相关炎症是肿瘤微环境的突出特征之一。癌症的发生发展与微环境中炎症因子的影响是分不开的。白细胞介素-6(IL-6)是调节肿瘤细胞生长的重要促炎因子。目前的研究发现,卵巢癌症患者IL-6和IL-6受体的表达均增加,这与临床预后不良密切相关。IL-6在卵巢癌症恶性进展中的作用机制一直是肿瘤微环境领域的研究热点。结合本组近年来的研究成果,主要综述了IL-6在卵巢癌症增殖、侵袭转移、血液系统疾病和耐药性中的作用。然后介绍了IL-6靶向治疗癌症的研究前沿和应用前景。关键词:卵巢癌症;白细胞介素6;炎症;肿瘤微环境;恶性进展
{"title":"Effect of interleukin6 on the malignant progression of ovarian cancer","authors":"Tongshuo Zhang, Ziyue Zhang, Weixin Li, Xiaoqin Guo","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.018","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.018","url":null,"abstract":"Modern oncology believes that tumor-associated inflammation is one of the prominent features of tumor microenvironment.The occurrence and development of ovarian cancer is inseparable from the influence of inflammatory factors in the microenvironment.Interleukin-6 (IL-6) is an important pro-inflammatory factor that regulates tumor cell growth.Current studies found that the expression of IL-6 and IL-6 receptor both increase in patients with ovarian cancer, which are closely related to poor clinical prognosis.The mechanism of effect of IL-6 on the malignant progression of ovarian cancer has been a research hotspots in the field of tumor microenvironment.In combination of the research results of this group in recent years, we mainly review the role of IL-6 in ovarian cancer including proliferation, invasion and metastasis, blood system disorders and drug resistance.Then, we introduce the research frontiers and application prospects of IL-6 targeted therapy for ovary cancer. \u0000 \u0000 \u0000Key words: \u0000Ovarian cancer; Interleukin6; Inflammation; Tumor microenvironment; Malignant progression","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43826683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the effect of different frequencysling exercise therapyon stroke patients 不同频率运动疗法对脑卒中患者影响的研究
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.012
Chaoqin Mao, Lizhi Yang, Zhiwen He, Jie Ma, Lilei Dai, Gang Wang
Objective To investigate the effects of different frequency sling exercise therapy (SET) on the balance of trunk control and walking ability in stroke patients. Methods A total of 90 patients with stroke who were admitted to the Department of Rehabilitation Medicine, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, from January 2018 to December 2018, received sling exercise therapy on a routine basis and were divided into 1 time/Day low frequency group, 2 time/Day medium frequency group, 3 time/Day high frequency group, 20 min/time, for a total of 3 months.After 1, 2 and 3 months, trunk control test (TCT), Berg balance scale(BBS), functional ambulation classification (FAC) and modified Barthel Index (MBI) were used to evaluate the three groups of patients. Results There were significant differences in TCT, BBS, FAC and MBI between the low, middle and high frequency groups (all P 0.05). There was no significant difference between fAC and MBI in the low, medium and high frequency group, but there was no significant difference between the two groups after training for 2 and 3 months There were significant differences between fAC ((1.84±0.41), (2.39±0.44), (3.29 ± 0.33) and MBI ((27.32 ± 9.33), (34.45 ± 9.21), (44.77 ± 10.27) and (41.33±11.21), (52.73±12.31), (75.94±13.22)). There was significant difference between the high frequency group and the low frequency group (P< 0.05). Conclusion Multiple sling exercise therapy in one day can further improve the balance of trunk control and walking ability of stroke patients, and shorten the course of disease. Key words: Stroke; Sling exercise therapy; Trunk control balance; Walking ability
目的探讨不同频率悬吊运动疗法(SET)对脑卒中患者躯干控制平衡及行走能力的影响。方法2018年1月~ 2018年12月华中科技大学同济医学院协和医院康复医学部收治的脑卒中患者90例,常规接受吊带运动治疗,分为1次/天低频组、2次/天中频组、3次/天高频组,每次20 min/次,共3个月。术后1、2、3个月采用躯干控制测验(TCT)、Berg平衡量表(BBS)、功能行走分级(FAC)和改良Barthel指数(MBI)对三组患者进行评价。结果低、中、高频组TCT、BBS、FAC、MBI差异均有统计学意义(P < 0.05)。低、中、高频组fAC与MBI差异无统计学意义,训练2、3个月后两组间差异无统计学意义。fAC((1.84±0.41)、(2.39±0.44)、(3.29±0.33)与MBI((27.32±9.33)、(34.45±9.21)、(44.77±10.27)、(41.33±11.21)、(52.73±12.31)、(75.94±13.22)之间差异有统计学意义。高频组与低频组比较差异有统计学意义(P< 0.05)。结论一天内多次吊带运动治疗可进一步改善脑卒中患者的躯干控制平衡和行走能力,缩短病程。关键词:卒中;吊带运动疗法;干线控制平衡;行走的能力
{"title":"Study on the effect of different frequencysling exercise therapyon stroke patients","authors":"Chaoqin Mao, Lizhi Yang, Zhiwen He, Jie Ma, Lilei Dai, Gang Wang","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.012","url":null,"abstract":"Objective \u0000To investigate the effects of different frequency sling exercise therapy (SET) on the balance of trunk control and walking ability in stroke patients. \u0000 \u0000 \u0000Methods \u0000A total of 90 patients with stroke who were admitted to the Department of Rehabilitation Medicine, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, from January 2018 to December 2018, received sling exercise therapy on a routine basis and were divided into 1 time/Day low frequency group, 2 time/Day medium frequency group, 3 time/Day high frequency group, 20 min/time, for a total of 3 months.After 1, 2 and 3 months, trunk control test (TCT), Berg balance scale(BBS), functional ambulation classification (FAC) and modified Barthel Index (MBI) were used to evaluate the three groups of patients. \u0000 \u0000 \u0000Results \u0000There were significant differences in TCT, BBS, FAC and MBI between the low, middle and high frequency groups (all P 0.05). There was no significant difference between fAC and MBI in the low, medium and high frequency group, but there was no significant difference between the two groups after training for 2 and 3 months There were significant differences between fAC ((1.84±0.41), (2.39±0.44), (3.29 ± 0.33) and MBI ((27.32 ± 9.33), (34.45 ± 9.21), (44.77 ± 10.27) and (41.33±11.21), (52.73±12.31), (75.94±13.22)). There was significant difference between the high frequency group and the low frequency group (P< 0.05). \u0000 \u0000 \u0000Conclusion \u0000Multiple sling exercise therapy in one day can further improve the balance of trunk control and walking ability of stroke patients, and shorten the course of disease. \u0000 \u0000 \u0000Key words: \u0000Stroke; Sling exercise therapy; Trunk control balance; Walking ability","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48077824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between the deletion of phosphatase and tensin homolog gene on chromosome 10, syncytin-1 and the damage of maternal endothelium and trophoblast in preeclampsia placenta 子痫前期胎盘10号染色体磷酸酶和张力素同源基因、合胞体-1缺失与母体内皮细胞和滋养层损伤的相关性
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.017
Xiaoshan Fang, Huijin Feng
Objective To study the correlation between phosphatase and tensin homolog deleted on chromosome ten(PTEN), Syncytin-1 in preeclamptic placenta and maternal endothelial injury, trophoblast injury. Methods From February 2015 to December 2017, 46 patients diagnosed as preeclampsia and delivered in Xiaolan Hospital Affiliated to Southern Medical University and 80 pregnant women with normal delivery in the same period were selected.Before delivery, maternal peripheral blood was collected and the content of endothelial injury markers was determined; after delivery, the placenta was retained and the expression of PTEN, Syncytin-1, apoptosis gene and the contents of oxidative stress markers were measured. Results The mRNA expression of PTEN in placental tissue of preeclampsia was significantly higher than that of normal placental tissue(t=32.797, P<0.000), and the mRNA expression of Syncytin-1 was significantly lower than that of normal placental tissue(t=28.506, P<0.001); the content of ET-1 and sFlt-1 in the blood circulation of the maternal body of preeclampsia was significantly higher than thsoe of normal pregnant women(t=39.884, 40.243; all P<0.000) and positively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=0.674, 0.596; P=0.004, 0.007), negatively correlated with the mRNA expression of Syncytin-1 in placenta(correlation coefficient=-0.615, -0.637; P<0.009, 0.008); the content of NO, PGI2, VEGF and PLGF were significantly lower than thse of normal pregnant women(t=30.944, 27.404, 32.827, 26.644; all P<0.001) and negatively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=-0.648, -0.592, -0.537, -0.613; P=0.006, 0.009, 0.013, 0.007), positively correlated with the mRNA expression of Syncytin-1 in placenta(correlation coefficient=0.632, 0.572, 0.537, 0.654; P<0.010, 0.013, 0.015, 0.009); The contents of NOX4, MDA, 8-OHdG and the mRNA expression of Fas, FasL, Bax, GRP78, CHOP, Caspase-3 in placental tissue of preeclampsia was significantly higher than that of normal placental tissue(t=27.714, 27.704, 26.786, 27.964, 22.622, 25.496, 25.893, 30.837, 28.975; all P<0.001) and positively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=0.703, 0.651, 0.593, 0.628, 0.449, 0.552, 0.612, 0.569, 0.502; P<0.003, 0.007, 0.004, 0.006, 0.016, 0.010, 0.006, 0.012, 0.018), negatively correlated with the mRNA expression of Syncytin-1 in placenta(correlation coefficient=-0.615, -0.714, -0.577, -0.548, -0.512, -0.585, -0.619, -0.495, -0.662; P<0.009, 0.001, 0.013, 0.015, 0.018, 0.011, 0.009, 0.023, 0.003); The contents of PrxII, PrxIII, SOD and mRNA expression of Bcl-2 in placental tissue of preeclampsia was significantly lower than that of normal placental tissue(t=26.115, 23.502, 17.194; all P<0.000) and negatively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=-0.713, -0.657, -0.591, -0.642; P<0.001, 0.006, 0.009, 0.007), posi
目的探讨子痫前期胎盘中10号染色体缺失的磷酸酶和张力素同源物(PTEN)、合胞素-1与母体内皮损伤、滋养层损伤的关系。方法选择2015年2月至2017年12月在南方医科大学附属小兰医院分娩的46例先兆子痫患者和同期正常分娩的80例孕妇。分娩前,采集产妇外周血,测定内皮损伤标志物含量;分娩后保留胎盘,检测PTEN、合胞素-1、凋亡基因的表达和氧化应激标志物的含量。结果子痫前期胎盘组织PTEN mRNA表达显著高于正常胎盘组织(t=32.797,P<0.000),合胞素-1 mRNA表达显著低于正常胎盘组织,t=28.506,P<0.001);子痫前期母体血液循环中ET-1和sFlt-1的含量显著高于正常孕妇(t=39.884,40.243;均<0.000),并与胎盘中PTEN的mRNA表达呈正相关(相关系数=0.6740.596;P=0.0004.007),与胎盘中合胞素-1的mRNA表达呈负相关(相关系数=0.615,-0.637;P<0.009,0.008);NO、PGI2、VEGF和PLGF含量显著低于正常孕妇(t=30.944、27.404、32.827、26.644;均<0.001),并与胎盘中PTEN的mRNA表达呈负相关(相关系数=0.648、-0.592、-0.537、-0.613;P=0.006、0.009、0.013、0.007),与胎盘中合胞素1的mRNA表达呈正相关(相关系数=0.632,0.572,0.537,0.654;P<0.010,0.013,0.015,0.009);NOX4、MDA、8-OHdG含量及Fas、FasL、Bax、GRP78、CHOP、,子痫前期胎盘组织中Caspase-3显著高于正常胎盘组织(t=27.714、27.704、26.786、27.964、22.622、25.496、25.893、30.837、28.975;均P<0.001),且与胎盘中PTEN的mRNA表达呈正相关(相关系数=0.703、0.651、0.593、0.628、0.449、0.552、0.612、0.569、0.502;P<0.003、0.007、0.004、0.006、0.016、0.010、0.006和0.012、0.018),与胎盘中合胞素-1的mRNA表达呈负相关(相关系数=-0.615、-0.714、-0.577、-0.548、-0.512、-0.585、-0.619、-0.495、-0.662;P<0.0019、0.013、0.015、0.018、0.011、0.009、0.023、0.003);子痫前期胎盘组织中PrxII、PrxIII、SOD含量和Bcl-2 mRNA表达显著低于正常胎盘组织(t=26.115、23.502、17.194;均P<0.000),并与胎盘中PTEN mRNA表达呈负相关(相关系数分别为-0.713、-0.657、-0.591、-0.642;P<0.001、0.006、0.009、0.007),结论子痫前期胎盘中PTEN的高表达和合胞素1的低表达可加重内皮细胞和滋养层的损伤。关键词:子痫前期;磷酸酶和张力蛋白同源物缺失的第十染色体基因;合胞素-1;内皮损伤;滋养细胞损伤
{"title":"Correlation between the deletion of phosphatase and tensin homolog gene on chromosome 10, syncytin-1 and the damage of maternal endothelium and trophoblast in preeclampsia placenta","authors":"Xiaoshan Fang, Huijin Feng","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.017","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.017","url":null,"abstract":"Objective \u0000To study the correlation between phosphatase and tensin homolog deleted on chromosome ten(PTEN), Syncytin-1 in preeclamptic placenta and maternal endothelial injury, trophoblast injury. \u0000 \u0000 \u0000Methods \u0000From February 2015 to December 2017, 46 patients diagnosed as preeclampsia and delivered in Xiaolan Hospital Affiliated to Southern Medical University and 80 pregnant women with normal delivery in the same period were selected.Before delivery, maternal peripheral blood was collected and the content of endothelial injury markers was determined; after delivery, the placenta was retained and the expression of PTEN, Syncytin-1, apoptosis gene and the contents of oxidative stress markers were measured. \u0000 \u0000 \u0000Results \u0000The mRNA expression of PTEN in placental tissue of preeclampsia was significantly higher than that of normal placental tissue(t=32.797, P<0.000), and the mRNA expression of Syncytin-1 was significantly lower than that of normal placental tissue(t=28.506, P<0.001); the content of ET-1 and sFlt-1 in the blood circulation of the maternal body of preeclampsia was significantly higher than thsoe of normal pregnant women(t=39.884, 40.243; all P<0.000) and positively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=0.674, 0.596; P=0.004, 0.007), negatively correlated with the mRNA expression of Syncytin-1 in placenta(correlation coefficient=-0.615, -0.637; P<0.009, 0.008); the content of NO, PGI2, VEGF and PLGF were significantly lower than thse of normal pregnant women(t=30.944, 27.404, 32.827, 26.644; all P<0.001) and negatively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=-0.648, -0.592, -0.537, -0.613; P=0.006, 0.009, 0.013, 0.007), positively correlated with the mRNA expression of Syncytin-1 in placenta(correlation coefficient=0.632, 0.572, 0.537, 0.654; P<0.010, 0.013, 0.015, 0.009); The contents of NOX4, MDA, 8-OHdG and the mRNA expression of Fas, FasL, Bax, GRP78, CHOP, Caspase-3 in placental tissue of preeclampsia was significantly higher than that of normal placental tissue(t=27.714, 27.704, 26.786, 27.964, 22.622, 25.496, 25.893, 30.837, 28.975; all P<0.001) and positively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=0.703, 0.651, 0.593, 0.628, 0.449, 0.552, 0.612, 0.569, 0.502; P<0.003, 0.007, 0.004, 0.006, 0.016, 0.010, 0.006, 0.012, 0.018), negatively correlated with the mRNA expression of Syncytin-1 in placenta(correlation coefficient=-0.615, -0.714, -0.577, -0.548, -0.512, -0.585, -0.619, -0.495, -0.662; P<0.009, 0.001, 0.013, 0.015, 0.018, 0.011, 0.009, 0.023, 0.003); The contents of PrxII, PrxIII, SOD and mRNA expression of Bcl-2 in placental tissue of preeclampsia was significantly lower than that of normal placental tissue(t=26.115, 23.502, 17.194; all P<0.000) and negatively correlated with the mRNA expression of PTEN in placenta(correlation coefficient=-0.713, -0.657, -0.591, -0.642; P<0.001, 0.006, 0.009, 0.007), posi","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43587917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国综合临床
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1